Oncology Video Sponsor

Search Results for the tag 'myeloma,'

03:56
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews experts in chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphoma, and multiple myeloma, and the...
by:imedex | 2381 views
06:00
Rafael Fonseca, MD Mayo Clinic Scottsdale, Arizona on multiple myeloma, novel agents and proteasome inhibitors American Society of Hematology 2011 (ASH) Watch Full Interview Here: http://elc.i...
by:imedex | 1703 views
07:15
Vincent Rajkumar, MD Mayo Clinic Rochester, Minnesota Multiple Myeloma, Carfilzomib, Dexamethasone and Lenalidomide Watch the full interview here: http://elc.i... More info on Carfilzmib: http://en.wi... More info on L...
by:imedex | 2340 views
12:57
Multiple Myeloma and Non-Hodgkin's Lymphoma Expert Video Viewpoints–Thou​ght Leader Perspectives on the Latest Hematology Advances with Sagal Lonial, MD. IMEReporting Live is a series of CME/CE-certifie​d videos that highlight emerging and evolving data reported at ASH 2011 on the treatment of multiple myeloma, lymphomas, and leukemias, and fea...
by:imeronline | 1998 views
07:41
Myeloma experts Dr. Bill Bensinger and Dr. Noopur Raje discuss the side effects associated with myeloma treatments, including neuropathy and fatigue, and the best strategies for coping. Although every patient is unique and may have different reactions to therapies, Drs. Raje and Bensinger stress the...
by:patientpower | 3467 views
03:52
Myeloma patients are at a higher risk of being diagnosed with a second cancer. It may be that their immune systems fails them again, or it could be a result of cancer fighting medicines. At the 9th European Congress on Hematologic Malignancies in Lyon, France, Dr. Meletios Dimopoulos from Athens, Gr...
by:patientpower | 1008 views
02:17
When myeloma patients become resistant to standard treatments, where can they turn? There are new drugs currently in clinical trials creating new hope for those who have become resistant to lenalidomide and bortezomib. Dr. Meletios Dimopoulos, an expert from Athens, Greece, joined us at the 9th European Congress on Hematologic Malignancies to share...
by:patientpower | 938 views
04:55
When people are first diagnosed with myeloma, they are met with some pretty scary words -- "incurable​" and "shortened lifespan" are terrifying to hear. Patient advocate, Jack Aiello has been living with myeloma for over 18 years and he has a lot of advice and comfort to give to t...
by:patientpower | 2968 views
03:34
Next generation of medicines are helping even the sickest patients with multiple myeloma live longer and better. In this video, Dr. Jesús San Miguel discusses some new information about a new immunomodulator drug that is proving effective for some patients who were no longer responding to standard t...
by:patientpower | 2170 views
03:21
Not long ago patients and patient advocacy groups were "downstrea​m" of research and science for cancer. But not anymore. Leading patient advocate and executive of Myeloma UK, Eric Low, says it is essential for both patients and their organizations to have a voice even at the early stages b...
by:patientpower | 2465 views
03:39
It's a time of great progress in developing new medicines for myeloma. In this video, patient advocate and executive of Myeloma UK, Eric Low, shares his measured excitement about all the positive changes in myeloma research. Hear his perspective on why we should be excited and hopeful with the pace...
by:patientpower | 2321 views
03:59
There has been an enormous buzz about oral therapies, and how they're changing the treatment landscape. But they may not be for everyone. Eric Low, chief executive of Myeloma UK and a leading patient advocate, gives us a different picture of what many patients consider when choosing their treatment option. And while oral therapies may seem more con...
by:patientpower | 2621 views
04:05
Dr Annamaria Brioli talks to ecancer at the 18th EHA Congress in Stockholm, Sweden about two studies that examine the use of cyclophosphamid​e lenalidomide and dexamethasone in myeloma. The first study analysed toxicity and the second looked at primary malignancy.
by:feeds | 1777 views
04:06
Pomalidomide, an investigational third-generatio​n immunomodulator​y drug, was more effective when combined with low-dose dexamethasone than high-dose in a clinical trial presented at the annual meeting of the American Society of Hematology. Patrice Wendling interviews Dr. Meletios A. Dimopoulos on wh...
by:feeds | 1849 views
23:27
In this edition of our ongoing video series, Dr. James Berenson updates us on a wide range of myeloma treatment options, the research that is impacting treatment, and answers your questions. Additionally, Dr. Berenson covers the risk of secondary cancers that may be associated with myeloma drugs an...
by:patientpower | 1260 views
00:43
Dr. Sergio Giralt, Chief Attending Physician at Memorial Sloan-Kettering Cancer Center, discusses management strategies for relapsed/refrac​tory myeloma including data on next-generation proteasome inhibitor and immunomodulator​y agent. A must see! http://www.m..._...
by:managingmyeloma | 2261 views
03:09
The University of Maryland Greenebaum Cancer Center has opened a new Phase I/IIa clinical trial for multiple myeloma. The trial is designed to investigate the safety, bioactivity and anti-tumor effect of infusion of patients' own T cells that have been genetically modified to express a high affinity T cell receptor (TCR) specific for a type of tumo...
by:umgcc | 2294 views
02:36
These daily streaming interviews with 6 different hematology thought leaders are focused on emerging scientific data and how it can be integrated into daily practice. Dr Morton Coleman interviews experts in chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphoma, and multiple myeloma, and the...
by:imedex | 2853 views
05:17
Dr. Maria-Victoria Mateos talks about a new study from Spain revealing how lower doses of newer drugs can be used in the long-term to fight cancer with much lower side effects.
by:patientpower | 2068 views
27:32
Hear how academic medicine saved Andrew's life.
by:patientpower | 1459 views
Sponsor
Oncology Video Sponsor
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)